Plasma anti-CD4 IgG is associated with brain abnormalities in people with HIV on antiretroviral therapy

J Neurovirol. 2021 Apr;27(2):334-339. doi: 10.1007/s13365-021-00966-0. Epub 2021 Mar 12.

Abstract

Anti-CD4 IgG autoantibodies have been implicated in CD4+ T cell reconstitution failure, leaving people with HIV (PWH) at heightened risk of HIV-associated comorbidities, such as neurocognitive impairment. Seventeen PWH on stable anti-retroviral therapy (ART) and 10 HIV seronegative controls had plasma anti-CD4 IgG antibodies measured by enzyme-linked immunosorbent assay. Neuropsychological (NP) tests assessed cognitive performance, and brain volumes were measured by structural magnetic resonance imaging. Anti-CD4 IgG levels were elevated (p = 0.04) in PWH compared with controls. Anti-CD4 IgG correlated with global NP z-scores (rho = - 0.51, p = 0.04). A relationship was observed between anti-CD4 IgG and putamen (β = - 0.39, p = 0.02), pallidum (β = - 0.38, p = 0.03), and amygdala (β = - 0.42, p = 0.05) regional brain volumes. The results of this study suggest the existence of an antibody-mediated relationship with neurocognitive impairment and brain abnormalities in an HIV-infected population.

Keywords: ART; Autoantibodies; Brain; CD4; CNS; Cognition; HIV.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS Dementia Complex / drug therapy
  • AIDS Dementia Complex / immunology*
  • Anti-HIV Agents / therapeutic use
  • Autoantibodies / blood*
  • Autoantigens / immunology
  • CD4 Antigens / immunology*
  • CD4-Positive T-Lymphocytes / immunology*
  • Cognitive Dysfunction / immunology
  • Cognitive Dysfunction / virology*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Middle Aged

Substances

  • Anti-HIV Agents
  • Autoantibodies
  • Autoantigens
  • CD4 Antigens
  • Immunoglobulin G